Do Systemic Alpha-2 Agonists Lower Glaucoma Risk? - Quiz - MDSpire

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

  • By

  • Andrea Surnit

  • July 8, 2026

  • 3 min

Share

Original Source(s)

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

  • by Andrea Surnit

  • July 8, 2026

Related Content

Research priorities for diagnostics, progression monitoring, and treatment of glaucoma in myopic eyes

Healthy Diet, Lower Glaucoma Risk

Population-based analysis links B vitamin intake to lower glaucoma risk

  • June 5, 2026

  • 3 min
Taking FLIGHT

ViaLase announces first commercial FLIGHT procedures in Europe

  • June 18, 2026

  • 2 min